Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients

Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients

Introduction: Lung cancer is the deadliest and most prevalent cancer worldwide. Lung cancer treatments have different characteristics and are associated with a range of benefits and side effects for patients. Such differences may raise uncertainty among drug developers, regulators, payers, and clini...

Full description

Bibliographic Details
Main Authors: Ilaria Durosini, Rosanne Janssens, Reinhard Arnou, Jorien Veldwijk, Meredith Y. Smith, Dario Monzani, Ian Smith, Giulia Galli, Marina Garassino, Eva G. Katz, Luca Bailo, Evelyne Louis, Marie Vandevelde, Kristiaan Nackaerts, G. Ardine de Wit, Gabriella Pravettoni, Isabelle Huys
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Public Health
Subjects:
patient preferences
drug decision-making
lung cancer
drug development
patient-centered research
patient involvement
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2021.622154/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2021.622154/full

Similar Items